Search Results 221-230 of 9760 for Primary biliary cholangitis

  1. Researchers link environmental exposures to liver disease - Mayo Clinic News Network

    ... primary sclerosing cholangitis, a rare, chronic liver disease of the bile ducts. The study, published in Exposome, represents a new frontier of research at ...

  2. Primary sclerosing cholangitis (PSC) - Doctors and departments - Mayo Clinic

    Scarring in the bile ducts blocks the flow of bile from the liver and damages liver tissue. A liver transplant is the only known cure.

  3. Vancomycin For Primary Sclerosing Cholangitis - Mayo Clinic

    The purpose of this study is to to assess the effects of different Oral Vancomycin (OV) doses on the clinical and biochemical course in adult patients with ...

  4. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

    Liver damage can result from this potentially serious disease in which scarring blocks the bile ducts. A liver transplant is the only known cure.

  5. Primary sclerosing cholangitis (PSC) - Doctors and departments - Mayo Clinic

    Scarring in the bile ducts blocks the flow of bile from the liver and damages liver tissue. A liver transplant is the only known cure.

  6. Mayo Clinic researchers announce discoveries from largest genome-wide study of chronic liver disease

    Researchers compared the genetic information of 4,796 primary sclerosing cholangitis patients against a control population of nearly 20,000 individuals, the ...

  7. Primary sclerosing cholangitis (PSC) - Doctors and departments - Mayo Clinic

    Scarring in the bile ducts blocks the flow of bile from the liver and damages liver tissue. A liver transplant is the only known cure.

  8. Primary sclerosing cholangitis (PSC) - Doctors and departments - Mayo Clinic

    tocellular carcinoma, Cirrhosis, Nonalcoholic fatty liver disease, Primary biliary cholangitis, Cholangiocarcinoma, Primary sclerosing cholangitis, Liver ...

  9. Phase 2b Study Of NGM282 Extended Treatment In Patients With Primary Biliary Cirrhosis - Mayo Clinic

    The purpose of this study is to determine the safety, tolerability, and activity of extended treatment with NGM282 in patients with Primary Biliary Cirrhosis.

  10. Elizabeth J. Carey, M.D. - Doctors and Medical Staff - Mayo Clinic

    Carey participates in liver disease research and professional activities related to primary biliary cholangitis ... MemberSteering Committee, TARGET-PBC (Primary ...